Facilities Registered As Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act)
Updated as of 8/28/15
This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
|Facility Name||Initial Date of Registration as an Outsourcing Facility1||Date of Most Recent Registration as an Outsourcing Facility1||End Date of Last FDA Inspection Related to Compounding2||Was a Form FDA-483 issued?3||Other FDA Action, if Any, Based on Last Inspection4,5||Intends to Compounds Sterile Drugs From Bulk Drug Substances6|
|ACS Dobfar Info S.A., Campascio, Switzerland||1/9/2015||1/9/2015||Not yet inspected||N/A||N/A||Yes|
Advanced Pharma, Inc., Houston, TX
|Alexander Infusion LLC dba Avanti Health Care, New Hyde Park, NY||4/21/2014||1/7/2015||7/9/2014||Yes||Warning Letter - 3/27/2015||Yes|
|AnazaoHealth Corporation, Las Vegas, NV||9/23/2014||12/29/2014||1/30/2015||Yes||Open||Yes|
|Avella Specialty Pharmacy, Phoenix, AZ||2/24/2014||1/20/2015||7/31/2015||Yes||Open7||No|
|Banner Health, Chandler, AZ||12/26/2013||1/27/2015||3/20/2015||Yes||Open||No|
|Brookfield Medical/Surgical Supply, Inc., Brookfield, CT||1/12/2015||1/12/2015||4/9/2015||Yes||Open||Yes|
|California Pharmacy and Compounding Center, Newport Beach, CA||4/30/2014||11/24/2014|
|Warning Letter - 6/17/2015||Yes|
|Cantrell Drug Company, Little Rock, AR||12/16/2013||12/30/2014||11/4/2013||Yes||Warning Letter - 1/21/2015||Yes|
|Central Admixture Pharmacy Services, Inc., Allentown, PA||2/28/2014||12/15/2014||2/11/2015||Yes||Open7||Yes|
Central Admixture Pharmacy Services, Inc., San Diego, CA
|Coastal Meds LLC, Biloxi, MS||12/23/2014||12/23/2014||11/10/2014||Yes||Open||Yes|
|Complete Pharmacy and Medical Systems, Miami Lakes, FL||6/6/2014||1/13/2015||8/12/2014||Yes||Open||Yes|
|Delta Pharma, Inc., Ripley, MS||8/6/2014||3/10/2015||10/2/2013||Yes||Warning Letter - 12/9/2014||Yes|
|Downing Labs, LLC, Dallas, TX||6/23/2015||6/23/2015||7/16/2014||Yes||FDA - Requested Recall Letter - 9/9/2014 7||Yes|
|Eagle Pharmacy, Inc., Birmingham, AL||6/16/2015||6/16/2015||8/21/2015||Yes||Open||Yes|
|Edge Pharmacy Services, LLC, Colchester, VT||1/21/2014||1/15/2015||8/20/2014||Yes||Open||Yes|
|Exela Pharma Sciences, LLC, Lenoir, NC||6/6/2014||1/5/2015||11/21/2014||Yes||Open||Yes|
Healix Infusion Therapy, Inc., Sugar Land, TX
|Hybrid Pharma, LLC, Deerfield Beach, FL||1/14/2015||1/14/2015||Not yet inspected||N/A||N/A||Yes|
|ILS Genomics, LLC Morrisville, NC||8/7/2015||8/7/2015||Not yet inspected||N/A||N/A||No|
|INCELL Corp., LLC, San Antonio, TX||5/29/2015||5/29/2015||Not yet inspected||N/A||N/A||Yes|
|Infusion Options Inc., Brooklyn, NY||1/24/2014||12/23/2014||4/23/2014||Yes||Open||No|
|Isomeric Pharmacy Solutions, LLC, Salt Lake City, UT||7/14/2015||7/14/2015||Not yet inspected||N/A||N/A||Yes|
JCB Laboratories, North Wichita, KS
|1/21/2014||11/25/2014||2/27/2013||Yes||Warning Letter - 7/7/2014||Yes|
|Jubilant HollisterStier LLC, Spokane, WA||6/3/2014||2/13/2015||12/02/2014||Yes||Open||Yes|
|Kings Park Slope, Inc., Brooklyn, NY||12/23/2013||1/5/2015||3/14/2014||Yes||Warning Letter - 3/27/2015||Yes|
|KRS Global Biotechnology, Inc., Boca Raton, FL||12/15/2013||1/7/2015||3/17/2014||Yes||Warning Letter - 7/6/2015||Yes|
|LeeSar, Inc., Fort Myers, FL||4/30/2014||1/30/2015||8/8/2014||Yes||Open||No|
|Leiter's Compounding, 17 Great Oaks Blvd., San Jose, CA||1/31/2014||1/26/2015||10/7/2014||Yes||Open||Yes|
|Medi-Fare Drug, Blacksburg, SC||12/17/2013||12/31/2014||9/12/2014||Yes||Open7||Yes|
|Medistat RX, LLC, Foley, AL||11/21/2014||11/21/2014||9/18/2014||Yes||Open||Yes|
|Nephron Sterile Compounding Center, LLC (NSCC), West Columbia, SC||7/15/2014||12/29/2014||Not yet inspected||N/A||N/A||Yes|
|OPS International Inc., Olympia Pharmacy, Orlando, FL||3/10/2014||1/27/2015||12/4/2014||Yes||Open7||Yes|
|Pharmaceutic Labs, LLC, Albany, NY||3/10/2014||1/28/2015||Not yet inspected||N/A||N/A||Yes|
|Pharmakon Pharmaceuticals, Noblesville, IN||1/23/2014||12/2/2014||3/13/2014; 4/8/2014|
|Warning Letter - 5/21/15||No|
|Pharmalogic CSP, Bridgeport, WV||7/1/2014||1/5/2015||12/12/2014||Yes||Open||Yes|
|Pharm D Solutions, LLC, Houston, TX||8/6/2014||3/24/2015||6/5/2015||Yes||Open||Yes|
PharMedium Services, LLC, Cleveland, MS
PharMedium Services, LLC, Edison, NJ
|PharMedium Services, LLC, Memphis, TN||12/11/2013||11/24/2014||7/10/2015|
PharMedium Services, LLC, Sugar Land, TX
|Warning Letter - 7/18/2014||No|
|Pine Pharmaceuticals, LLC, Tonawanda, NY||6/17/2014||12/29/2014||10/16/2014||No||No||Yes|
|Pinnacle Compounding Pharmacy, Las Vegas, NV||7/10/2015||7/10/2015||7/31/2015||Yes||Open||Yes|
|Premier Pharmacy Labs Inc., Weeki Wachee, FL||4/16/2014||12/18/2014||5/9/2014||Yes||Warning Letter - 4/27/2015||Yes|
|Qualgen LLC, formerly registered as Amerilab LLC, Edmond, OK||5/23/2014||5/8/2015||Not yet inspected||N/A||N/A||Yes|
|Region Care, Inc., Great Neck, NY||12/24/2013||1/7/2015||3/20/2014||Yes||Warning Letter - 4/8/2015||Yes|
|RXQ Compounding LLC, Athens, OH||1/2/2015||1/2/2015||Not yet inspected||N/A||N/A||Yes|
SCA Pharmaceuticals, Little Rock, AR
|Yes||Warning Letter - 6/25/2015||Yes|
|SSM St. Clare Health Center, Fenton, MO||2/18/2014||1/5/2015||8/14/2014||Yes||Open||No|
|STERRX, LLC, Plattsburgh, NY||5/29/2015||5/29/2015||Not yet inspected||N/A||N/A||Yes|
Triangle Compounding Pharmacy Inc., Cary, NC
|Yes (9/22/2014 and 1/16/2015)||Open7||Yes|
|Unique Pharmaceuticals, Ltd., Temple TX||1/17/2014||11/25/2014|
|US Compounding, Inc., Conway, AR||12/20/2013||12/24/2014||8/21/2015||Yes||Open7||Yes|
US Specialty Formulations LLC, Bethlehem, PA
1. The "initial date of registration as an outsourcing facility" is the date the facility was first registered (i.e., the date FDA determined that the initial registration information submitted for the facility was complete, and for firms first registering onor after October 1, 2014, the establishment fee was paid in full).
Under section 503B(b) of the FD&C Act, after the initial registration, a facility that elects to continue to be registered with FDA as an outsourcing facility must re-register annually. Beginning in fiscal year (FY) 2015 (October 1, 2014 to September 30, 2015), a facility that elects to register (or re-register) with FDA as an outsourcing facility must pay an annual establishment fee. The “date of most recent registration as an outsourcing facility” reflects the date FDA determined the most recently submitted registration information was complete and the annual establishment fee for that fiscal year paid in full.
Unless a previously registered outsourcing facility re-registers and pays the annual establishment fee in full during the registration period (between October 1 and December 31 of each calendar year), the facility will be removed from the list of registered outsourcing facilities on January 1 of the next calendar year.
2. Inspections identified in this table are associated with the facility at the listed address. A company may own or operate more than one registered outsourcing facility. FDA’s web page Compounding: Inspections, Recalls, and Other Actions may contain information about compounding facilities under the same ownership as the listed registered outsourcing facility.
Inspections may take place over several days, weeks, or longer. The date of the inspection is the date a Form FDA-483 listing the investigators' observations was issued. If no FDA Form-483 was issued, the date is the last day of the inspection.
3. A Form FDA-483 is issued when investigators observe any significant objectionable conditions. It does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.
4. This table reflects only FDA actions. It does not include State Board of Pharmacy actions, if any. To determine whether a registered outsourcing facility has been the subject of a state enforcement action, check with the State Board of Pharmacy for the state in which the facility is located. Some states post disciplinary or other actions on their web sites.
5. "Closed" means the inspection has been closed without further action. "Open" means that FDA has not made a determination as to whether further action will be taken. If an action has been taken, it will be listed. Possible FDA actions include: warning letter; seizure; or injunction.
6. The information in this column was provided by the registered outsourcing facility at the time of registration and has not been verified by FDA. “N/A”, indicates the registered outsourcing facility has not provided this information. In the future, FDA intends to provide information about whether the outsourcing facility also intends to compound nonsterile drugs from bulk drug substances. That information is not currently available to the Agency.
7. This facility was the subject of at least one previous inspection relating to compounding that resulted in a Form 483, warning letter, or other action. For information about such inspections and resulting actions, see Compounding: Inspections, Recalls, and other Actions.